Frequency Therapeutics has raised $32 million to help finance the development of its therapy for noise-induced hearing loss. The Woburn, Massachusetts-based firm specialises in small molecule ...
Trevi Therapeutics (TRVI) announced topline results from its Phase 2a RIVER trial of Haduvio for the treatment of patients with RCC. Haduvio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback